People Matter


Cambridge, MA, USA · Medford, MA, USA · Cambridge, MA, USA · Boston, MA, USA


Biotechnology · DeepTech · Health


11-50 employees



founded in


Travera commercializes a breakthrough measurement technology and biomarker developed in the Manalis Laboratory in the Koch Institute for Integrative Cancer Research at MIT. The core technology, a MEMS device called the Suspended Microchannel Resonator (SMR), is an exquisitely sensitive scale that can measure a small change in the weight of a single cancer cell. When cancer cells respond to cancer drugs, they start their process of dying by changing weight in just a few hours. The SMR can detect this tiny weight change. As most cancer cells die naturally within 1-2 days of being removed from the human body, speed is critical to distinguish between natural cell death and cell death induced by a cancer drug. It is this exquisite sensitivity that enables the SMR to detect a cancer cell’s response to a cancer drug while it is still a viable cell. The company was founded in 2017 and is headquartered in Cambridge, Massachusetts.

Something looks off?
Open jobs at Travera
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.